Menu
GeneBe

SRGN

serglycin, the group of Proteoglycans

Basic information

Region (hg38): 10:69088102-69104805

Previous symbols: [ "PRG", "PRG1" ]

Links

ENSG00000122862NCBI:5552OMIM:177040HGNC:9361Uniprot:P10124AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SRGN gene.

  • not provided (3 variants)
  • Inborn genetic diseases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SRGN gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
1
clinvar
2
clinvar
3
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 1 1 2

Variants in SRGN

This is a list of pathogenic ClinVar variants found in the SRGN region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
10-69088186-G-A not specified Uncertain significance (Jan 24, 2024)3169987
10-69088188-C-T not specified Uncertain significance (Oct 17, 2023)3169989
10-69097207-C-G Benign (Jul 26, 2018)710351
10-69097209-C-A not specified Uncertain significance (Feb 27, 2024)3169985
10-69103892-G-C not specified Uncertain significance (Jun 26, 2023)2606333
10-69103897-G-A not specified Uncertain significance (Nov 07, 2023)3169986
10-69103942-C-T Benign (Jul 26, 2018)790085
10-69103944-G-A not specified Uncertain significance (Jun 09, 2022)3169988
10-69103949-C-T Benign/Likely benign (Apr 01, 2022)735160

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SRGNprotein_codingprotein_codingENST00000242465 316706
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.6970.28800000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.5967692.10.8250.000005301026
Missense in Polyphen1924.9240.76232317
Synonymous0.9582835.20.7950.00000199315
Loss of Function1.8303.910.001.66e-746

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays a role in formation of mast cell secretory granules and mediates storage of various compounds in secretory vesicles. Required for storage of some proteases in both connective tissue and mucosal mast cells and for storage of granzyme B in T-lymphocytes. Plays a role in localizing neutrophil elastase in azurophil granules of neutrophils. Mediates processing of MMP2. Plays a role in cytotoxic cell granule-mediated apoptosis by forming a complex with granzyme B which is delivered to cells by perforin to induce apoptosis. Regulates the secretion of TNF- alpha and may also regulate protease secretion. Inhibits bone mineralization. {ECO:0000269|PubMed:11911826, ECO:0000269|PubMed:16420477, ECO:0000269|PubMed:16870619}.;
Pathway
Glucocorticoid Receptor Pathway;Nuclear Receptors Meta-Pathway;Platelet degranulation ;Response to elevated platelet cytosolic Ca2+;Platelet activation, signaling and aggregation;Hemostasis (Consensus)

Recessive Scores

pRec
0.216

Intolerance Scores

loftool
0.407
rvis_EVS
0.7
rvis_percentile_EVS
85.42

Haploinsufficiency Scores

pHI
0.709
hipred
N
hipred_score
0.296
ghis
0.405

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.489

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Srgn
Phenotype
hematopoietic system phenotype; immune system phenotype;

Gene ontology

Biological process
platelet degranulation;granzyme-mediated apoptotic signaling pathway;protein processing;negative regulation of bone mineralization;biomineral tissue development;mast cell secretory granule organization;T cell secretory granule organization;maintenance of protease location in mast cell secretory granule;maintenance of granzyme B location in T cell secretory granule;negative regulation of cytokine secretion
Cellular component
extracellular region;extracellular space;Golgi apparatus;platelet alpha granule lumen;mast cell granule
Molecular function
protein binding